In an amicus brief filed in Ortho Biotech Products v. United States ex rel. Mark Eugene Duxbury, the AHA said that if the First Circuit Court of Appeals’ decision were not reversed, it would undermine two key requirements for FCA actions:
- That private individuals attempting to bring lawsuits not trade on fraud allegations already disclosed to the public; and
- That they have specific knowledge of false or fraudulent claims before filing the case.
Read AHA News Now’s report on the False Claims Act.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
